Stargardt disease and the role of vitamin A: Disease pathogenesis and the promise of oral therapies

touchEXPERT FOCUS for touchOPHTHALMOLOGY

Listen to an interview with Dr. Christine Kay on the role of vitamin A in the retina, how vitamin A processing is disrupted in Stargardt disease, and the mechanism of action, emerging clinical evidence, and key safety considerations for emerging oral therapies.

The expert:

• Dr. Christine Kay, Vitreoretinal Associates, Gainesville, FL, USA

This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc.

This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.

This touchPODCAST is for HCPs outside of the UK.

For further information visit our website: https://touchophthalmologyime.org/stargardt-disease-and-vitamin-a/